Platelets

Bacterial contamination of platelet components, passive vs. active, surveillance, testing and pathogen reduction technologies

Dr. Richard J. Benjamin, MBChB, PhD, FRCPath
Cerus Corporation,
Concord, California, USA

Platelets

Safety surveillance and the introduction of pathogen reduced platelets: the role of national hemovigilance systems in the Cerus post-market clinical follow-up strategy

Dr. John Pitman, PhD
Cerus Corporation
Concord, USA

Platelets

Overview of the variability in platelet production processes and applied safety measures

Dr. Mohammad R. Abedi, PhD
Örebro University Hospital
Örebro, Sweden